Solution Spotlight: IQVIA CTFS Site Payments
IQVIA Clinical Trial Financial Suite (CTFS) is a next-generation platform designed to modernise clinical trial financial operations. CTFS Site Payments, a module on the platform, enables execution of investigator site payments in an accurate, transparent, and timely manner through AI-assisted automation and standardised workflows. IQVIA CTFS Site Payments reduces manual effort and manages global payment complexity with agentic AI to yield faster cycle times and higher site satisfaction.
What problem or status quo deficiency are you solving?
Site payments remain one of the most fragmented and labour-intensive aspects of clinical trial financial management. Across many organisations, they are managed as a siloed function, supported by disconnected systems and manual processes that introduce inefficiencies, increase the risk of errors, and make it difficult to maintain consistency and oversight.
This fragmentation is particularly evident in critical activities, such as contract interpretation, invoice processing, and payment execution. For example, Clinical Trial Agreements (CTAs) are often received in different formats and require manual data transfer into payment systems, which is time-consuming and prone to delays and inaccuracies.
The result is limited transparency into payment status, challenges with reconciliation, and inconsistent processes across global studies. Sponsors, CROs, and sites lack a single source of truth, which creates friction in day-to-day operations and adds administrative burden.
CTFS Site Payments is designed to address this specific operational gap by transforming site payments from a fragmented process into a unified, end-to-end workflow. It brings automation, standardised processes, and real-time tracking into a single environment, improving visibility, reducing manual effort, and enabling more consistent, controlled payment operations.
What new innovations does your solution bring to bear on these challenges?
CTFS Site Payments applies agentic AI to automate key stages of the site payment process where manual work has traditionally created delays and errors. This includes supporting the ingestion of contract and invoice data, identifying exceptions or anomalies, and accelerating routine payment workflows. The goal is to maximise the impact of human oversight by reducing repetitive tasks so teams can focus on high-value review, control, and decision-making. This reflects a broader industry movement toward pairing advanced technology with deep domain expertise — using automation to improve speed and accuracy while relying on experienced teams to manage complexity and ensure quality.
Standardised workflows help bring consistency to site payment operations while allowing for customised configurations to meet the needs of different study designs, payment terms, and regional requirements. The solution also supports different operating models, recognising that organisations vary in how much they choose to manage internally versus through specialised services. This flexibility allows sponsors and CROs to modernise site payment operations without forcing a one-size-fits-all approach.
How does your solution work?
CTFS Site Payments operates as a unified, SaaS-based solution with flexible deployment options, supporting insourced, outsourced, or hybrid payment management models. This enables organisations to align execution with their operational structure and geographic footprint.
At its core, the solution ingests key data elements — including CTAs, budgets, EDC data, and invoices — and standardises them within a single environment. AI-driven CTA and invoice ingestion extracts relevant terms from multiple formats, reducing the need for manual data entry and enabling downstream processing.
Once data is structured, CTFS Site Payments orchestrates end-to-end workflows across invoice creation, validation, approvals, and payment execution. Built-in controls, such as anomaly detection and audit trails, support financial governance and global tax compliance while ensuring traceability and consistency.
Real-time tracking and reporting provide visibility into payment status for both sponsors and sites, supported by self-service tools and centralised dashboards. This allows teams to monitor progress, investigate discrepancies, and manage amendments within the same system.
The result is a connected, standardised payment process that reduces manual effort and enables teams to focus on oversight, with automation handling routine activities.
What makes your solution stand out in the market?
CTFS Site Payments stands out by addressing site payments as a unified, end-to-end process that is connected to upstream and downstream processes, rather than a standalone, fragmented function. As part of the Clinical Trial Financial Suite, it converts site payments into a connected workflow within a single platform, eliminating siloed systems and manual effort.
Flexibility is another differentiator. CTFS Site Payments supports insourced, outsourced, or hybrid operating models, enabling organisations to align payment management with their internal capabilities and global regulations. For clinical trial sponsors seeking more than purely software, IQVIA experts — with decades of global clinical trial financial experience — can support complex global trials with varying regulatory, tax, and banking requirements.
Finally, the platform provides real-time payment tracking, reporting, and self-service tools for both sponsors and sites, creating greater transparency and control. Combined with a globally scalable, AI-enabled foundation and deep subject matter expertise, this delivers a more consistent and efficient approach to managing site payments.
How does your solution improve the experience for the end user?
For investigator sites, CTFS Site Payments is designed to improve payment timeliness, predictability, and transparency. Clearer visibility into payment status and reconciliation reduces uncertainty and minimises administrative follow-ups. More consistent and accurate payments help sites better manage cash flow and focus their resources on patient care and trial delivery.
Sponsors and CROs benefit from improved oversight and operational efficiency, with greater consistency across studies and regions and reduced manual effort tied to site payment management. By streamlining payment execution and improving transparency, organisations can reduce operational friction and strengthen site relationships.
Improving the site payment experience ultimately supports better trial execution. When sites have confidence in payment processes, they are better positioned to engage fully in trial activities, which benefits sponsors, CROs, and patients alike.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions and Healthcare-grade AI® are powered by IQVIA Connected Intelligence™ to deliver actionable insights and accelerate innovations. With approximately 93,000 employees in over 100 countries, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at www.iqvia.com.


